Guggenheim initiated coverage of Celcuity (CELC) with a Buy rating and $110 price target
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CELC:
- Short Report: Celcuity short interest at two-year high
- Celcuity’s Enhanced Financial Flexibility and Strategic Progress Justify Buy Rating
- Celcuity Expands Credit Facility to $500 Million
- Celcuity Inc. Earnings Call: Clinical Progress and Financial Fortification
- Celcuity’s Gedatolisib Gains Momentum with FDA’s RTOR Program and Promising Phase 3 Trial Results